FFM
Fairmount Funds Management Portfolio holdings
AUM
$772M
This Quarter Return
-10.23%
1 Year Return
+35.05%
3 Year Return
+1,168.51%
5 Year Return
+1,432.11%
10 Year Return
–
AUM
$243M
AUM Growth
+$243M
(+2.5%)
Cap. Flow
+$31.5M
Cap. Flow
% of AUM
12.94%
Top 10 Holdings %
Top 10 Hldgs %
76.36%
Holding
21
New
–
Increased
13
Reduced
3
Closed
2
Top Buys
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$9.76M |
| 2 |
Insmed
INSM
|
$9.17M |
| 3 |
Astria Therapeutics
ATXS
|
$8.52M |
| 4 |
PNT
POINT Biopharma Global Inc. Common Stock
PNT
|
$8.36M |
| 5 |
argenx
ARGX
|
$5.33M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$11.6M |
| 2 |
Seres Therapeutics
MCRB
|
$7.27M |
| 3 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$4.14M |
| 4 |
Iovance Biotherapeutics
IOVA
|
$1.56M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$207K |
Sector Composition
| 1 | Healthcare | 96.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Insmed
INSM
$28.8B
| $36.5M | 15.02% | 1,283,887 +322,090 | +33% | +$9.17M |
|
|
ZGNX
2
DELISTED
Zogenix, Inc.
ZGNX
| $34M | 14% | 1,970,259 +565,000 | +40% | +$9.76M |
|
3
Axsome Therapeutics
AXSM
$6.05B
| $21.1M | 8.67% | 312,598 +61,000 | +24% | +$4.12M |
|
|
4
argenx
ARGX
$43.6B
| $20.8M | 8.56% | 69,144 +17,694 | +34% | +$5.33M |
|
|
5
Iovance Biotherapeutics
IOVA
$807M
| $13.2M | 5.41% | 505,890 -60,000 | -11% | -$1.56M |
|
6
Instil Bio
TIL
$182M
| $13M | 5.35% | 673,905 +123,905 | +23% | +$2.39M |
|
|
ALLK
7
DELISTED
Allakos
ALLK
| $13M | 5.34% | 152,162 +4,500 | +3% | +$384K |
|
8
Cogent Biosciences
COGT
$1.69B
| $12.6M | 5.2% | 1,558,975 | – | – |
|
|
AMRN
9
Amarin Corp
AMRN
$311M
| $11.1M | 4.56% | 2,533,237 +925,000 | +58% | +$4.05M |
|
|
10
Acadia Pharmaceuticals
ACAD
$4.38B
| $10.3M | 4.25% | 423,817 -8,500 | -2% | -$207K |
|
|
PNT
11
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $8.88M | 3.65% | 864,214 +814,214 | +1,628% | +$8.36M |
|
|
TRIL
12
DELISTED
Trillium Therapeutics Inc.
TRIL
| $8.69M | 3.57% | 896,281 -426,900 | -32% | -$4.14M |
|
|
13
Astria Therapeutics
ATXS
$349M
| $8.63M | 3.55% | 4,092,166 +4,039,000 | +7,597% | +$8.52M |
|
14
Amicus Therapeutics
FOLD
$2.34B
| $8.57M | 3.52% | 888,980 +100,000 | +13% | +$964K |
|
15
Enanta Pharmaceuticals
ENTA
$180M
| $7.84M | 3.22% | 178,058 +6,911 | +4% | +$304K |
|
|
GBT
16
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $7.35M | 3.02% | 210,000 +35,000 | +20% | +$1.23M |
|
17
Keros Therapeutics
KROS
$618M
| $6.34M | 2.61% | 149,333 +40,000 | +37% | +$1.7M |
|
18
Viridian Therapeutics
VRDN
$1.5B
| $642K | 0.26% | 35,092 | – | – |
|
|
VRNA
19
Verona Pharma
VRNA
$9.16B
| $549K | 0.23% | 83,944 | – | – |
|
|
20
Seres Therapeutics
MCRB
$166M
| – | – | -353,016 | Closed | -$7.27M |
|
|
MRTX
21
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – | -67,800 | Closed | -$11.6M |
|